摘要
目的:比较1,25(OH)2D3口服冲击与血液灌流对维持性血液透析患者继发甲状旁腺功能亢进(SHPT)的疗效与护理。方法:将维持性血液透析SHPT患者42例随机分成A组[1,25(OH)2D3口服冲击组]及B组(血液灌流组)各21例。A组在1周3次血液透析治疗基础上给予1,25(OH)2D3口服冲击;B组给予1周3次血液灌流串联血液透析治疗。比较治疗后两组血清全段反应性甲状旁腺激素(iPTH)和皮肤瘙痒等改善情况,并探讨护理要点。结果:治疗12周后两组患者iPTH与治疗前相比具有显著性(P<0.01),但B组下降程度较A组更为显著(P<0.01)。结论:血液灌流对维持性血液透析患者SHPT的疗效比1,25(OH)2D3口服冲击更明显,且皮肤瘙痒等症状好转,值得临床推广。
Objective:To compare clinical observation of efficacy of 1,25(OH)2D3 oral pulse and hemoperfusion cure secondary hyperparathyroidism in maintenance hemodialysis patients and nursing.Methods:42 maintenance hemodialysis SHPT patients were radomly divided into group A[1,25(OH)2D3 oral pulse]21 cases and group B (hemoperfusion) 21 cases. Group A accepted 1,25(OH)2D3 oral pulse based hemodialysis three times a week,and group B accepted hemoperfusion and hemodialysis.After treatment to compare two sets of iPTH and pruritus and nursing points.Results:After treatment 12 weeks the iPTH in two groups has significant than before treatment(P〈0.01), but the decline degree of group B better than group A(P〈0.01). Conclusion:Hemoperfusion cure secondary hyperparathyroidism in maintenance hemodialysis patients better than 1,25(OH)2D3 oral pulse,improve pruritus, It is worth popularizing.
出处
《护理实践与研究》
2010年第13期23-24,共2页
Nursing Practice and Research